France has clamped down on the much-talked about drug that many have taken against Covid-19, including US President Donald Trump. A new study showed that the treatment increases the risk of death from the virus.

The French government has revoked its decree authorizing the prescription of anti-malarial drug hydroxychloroquine (HCQ) for treating Covid-19 patients, with the exception of clinical trials. The decision came after the government’s advisory body, the High Council of Public Health (HCPS), and the National Agency for Medicines and Health Products Safety (ANSM) both gave unfavorable opinions on the drug.

The HCPS recommended against using hydroxychloroquine outside of clinical trials, regardless of whether the patients took the drug alone or in combination with antibiotics. The ANSM, in turn, initiated a procedure to suspend clinical trials involving the use of HCQ “as a precaution.”

The drug has become a buzzword in the media as many place high hopes on finding a cure for the novel coronavirus. HCQ became increasingly popular in France to fight Covid-19 symptoms, as its prescription rate jumped by 7,000 percent in some parts of the country, according to local media. (RT)